306 related articles for article (PubMed ID: 17510401)
41. Evidence for a CDK4-dependent checkpoint in a conditional model of cellular senescence.
Brookes S; Gagrica S; Sanij E; Rowe J; Gregory FJ; Hara E; Peters G
Cell Cycle; 2015; 14(8):1164-73. PubMed ID: 25695870
[TBL] [Abstract][Full Text] [Related]
42. Identification of p18 INK4c as a tumor suppressor gene in glioblastoma multiforme.
Solomon DA; Kim JS; Jenkins S; Ressom H; Huang M; Coppa N; Mabanta L; Bigner D; Yan H; Jean W; Waldman T
Cancer Res; 2008 Apr; 68(8):2564-9. PubMed ID: 18381405
[TBL] [Abstract][Full Text] [Related]
43. Structure-based design of p18INK4c proteins with increased thermodynamic stability and cell cycle inhibitory activity.
Venkataramani RN; MacLachlan TK; Chai X; El-Deiry WS; Marmorstein R
J Biol Chem; 2002 Dec; 277(50):48827-33. PubMed ID: 12370184
[TBL] [Abstract][Full Text] [Related]
44. A defect of the INK4-Cdk4 checkpoint and Myc collaborate in blastoid mantle cell lymphoma-like lymphoma formation in mice.
Vincent-Fabert C; Fiancette R; Rouaud P; Baudet C; Truffinet V; Magnone V; Guillaudeau A; Cogné M; Dubus P; Denizot Y
Am J Pathol; 2012 Apr; 180(4):1688-701. PubMed ID: 22326754
[TBL] [Abstract][Full Text] [Related]
45. Small-molecule inhibitors targeting INK4 protein p18(INK4C) enhance ex vivo expansion of haematopoietic stem cells.
Gao Y; Yang P; Shen H; Yu H; Song X; Zhang L; Zhang P; Cheng H; Xie Z; Hao S; Dong F; Ma S; Ji Q; Bartlow P; Ding Y; Wang L; Liu H; Li Y; Cheng H; Miao W; Yuan W; Yuan Y; Cheng T; Xie XQ
Nat Commun; 2015 Feb; 6():6328. PubMed ID: 25692908
[TBL] [Abstract][Full Text] [Related]
46. S-phase lengthening induced by p16(INK4a) overexpression in malignant cells with wild-type pRb and p53.
Chien WW; Domenech C; Catallo R; Salles G; Ffrench M
Cell Cycle; 2010 Aug; 9(16):3286-96. PubMed ID: 20703084
[TBL] [Abstract][Full Text] [Related]
47. Tumor suppressor INK4: determination of the solution structure of p18INK4C and demonstration of the functional significance of loops in p18INK4C and p16INK4A.
Li J; Byeon IJ; Ericson K; Poi MJ; O'Maille P; Selby T; Tsai MD
Biochemistry; 1999 Mar; 38(10):2930-40. PubMed ID: 10074345
[TBL] [Abstract][Full Text] [Related]
48. Conspirators in a capital crime: co-deletion of p18INK4c and p16INK4a/p14ARF/p15INK4b in glioblastoma multiforme.
Solomon DA; Kim JS; Jean W; Waldman T
Cancer Res; 2008 Nov; 68(21):8657-60. PubMed ID: 18974105
[TBL] [Abstract][Full Text] [Related]
49. G1 arrest by p16INK4A uncouples growth from cell cycle progression in leukemia cells with deregulated cyclin E and c-Myc expression.
Ausserlechner MJ; Obexer P; Geley S; Kofler R
Leukemia; 2005 Jun; 19(6):1051-7. PubMed ID: 15800668
[TBL] [Abstract][Full Text] [Related]
50. Disruption of the cyclin D/cyclin-dependent kinase/INK4/retinoblastoma protein regulatory pathway in human neuroblastoma.
Easton J; Wei T; Lahti JM; Kidd VJ
Cancer Res; 1998 Jun; 58(12):2624-32. PubMed ID: 9635589
[TBL] [Abstract][Full Text] [Related]
51. Evidence of a role for the INK4 family of cyclin-dependent kinase inhibitors in ovarian granulosa cell tumors.
Arcellana-Panlilio MY; Egeler RM; Ujack E; Magliocco A; Stuart GC; Robbins SM; Coppes MJ
Genes Chromosomes Cancer; 2002 Oct; 35(2):176-81. PubMed ID: 12203782
[TBL] [Abstract][Full Text] [Related]
52. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
[TBL] [Abstract][Full Text] [Related]
53. Intrinsic cooperation between p16INK4a and p21Waf1/Cip1 in the onset of cellular senescence and tumor suppression in vivo.
Takeuchi S; Takahashi A; Motoi N; Yoshimoto S; Tajima T; Yamakoshi K; Hirao A; Yanagi S; Fukami K; Ishikawa Y; Sone S; Hara E; Ohtani N
Cancer Res; 2010 Nov; 70(22):9381-90. PubMed ID: 21062974
[TBL] [Abstract][Full Text] [Related]
54. p18Ink4c collaborates with Men1 to constrain lung stem cell expansion and suppress non-small-cell lung cancers.
Pei XH; Bai F; Smith MD; Xiong Y
Cancer Res; 2007 Apr; 67(7):3162-70. PubMed ID: 17409423
[TBL] [Abstract][Full Text] [Related]
55. p16INK4A mediates cyclin dependent kinase 4 and 6 inhibition in senescent prostatic epithelial cells.
Sandhu C; Peehl DM; Slingerland J
Cancer Res; 2000 May; 60(10):2616-22. PubMed ID: 10825132
[TBL] [Abstract][Full Text] [Related]
56. Cdkn2a, the cyclin-dependent kinase inhibitor encoding p16INK4a and p19ARF, is a candidate for the plasmacytoma susceptibility locus, Pctr1.
Zhang S; Ramsay ES; Mock BA
Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2429-34. PubMed ID: 9482902
[TBL] [Abstract][Full Text] [Related]
57. Inactivation of the Dlc1 gene cooperates with downregulation of p15INK4b and p16Ink4a, leading to neoplastic transformation and poor prognosis in human cancer.
Qian X; Durkin ME; Wang D; Tripathi BK; Olson L; Yang XY; Vass WC; Popescu NC; Lowy DR
Cancer Res; 2012 Nov; 72(22):5900-11. PubMed ID: 23010077
[TBL] [Abstract][Full Text] [Related]
58. Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma.
Ely S; Di Liberto M; Niesvizky R; Baughn LB; Cho HJ; Hatada EN; Knowles DM; Lane J; Chen-Kiang S
Cancer Res; 2005 Dec; 65(24):11345-53. PubMed ID: 16357141
[TBL] [Abstract][Full Text] [Related]
59. INK4 proteins, a family of mammalian CDK inhibitors with novel biological functions.
Cánepa ET; Scassa ME; Ceruti JM; Marazita MC; Carcagno AL; Sirkin PF; Ogara MF
IUBMB Life; 2007 Jul; 59(7):419-26. PubMed ID: 17654117
[TBL] [Abstract][Full Text] [Related]
60. Haploinsufficiency of p18(INK4c) sensitizes mice to carcinogen-induced tumorigenesis.
Bai F; Pei XH; Godfrey VL; Xiong Y
Mol Cell Biol; 2003 Feb; 23(4):1269-77. PubMed ID: 12556487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
